TABLE-Orchid July-Sept net loss narrows

Oct 30 (Reuters) - Three months ended Sept 30

(Versus the same period a year earlier, in million rupees unless stated)

Net Loss 132 vs 406.6

Net Sales 3,048.5 vs 3,391.4

Results are standalone

NOTE: Orchid Chemicals and Pharmaceuticals (ORCD.BO) is primarily a manufacturer of oral and sterile bulk drugs with a special focus on cephalosporins.

(Reporting by Nandita Bose; Editing by Sunil Nair)